Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 DKK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 810,636 Less Arrow 536,510 Less Arrow 166,765
Financial expenses 76,805 Less Arrow 25,172 Less Arrow 6,728
Earnings before taxes -306,967 More Arrow -273,586 Less Arrow -373,290
EBITDA -239,426 Less Arrow -273,327 Less Arrow -381,348
Total assets 1,248,807 More Arrow 1,305,041 Less Arrow 1,061,546
Current assets 856,487 More Arrow 943,682 Less Arrow 736,418
Current liabilities 273,468 Less Arrow 217,329 Less Arrow 98,487
Equity capital 224,881 More Arrow 512,042 More Arrow 733,153
- share capital 1,601 Less Arrow 1,592 Less Arrow 1,523
Employees (average) 181 Less Arrow 86 Less Arrow 56

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 18.0% More Arrow 39.2% More Arrow 69.1%
Turnover per employee 4,479 More Arrow 6,238 Less Arrow 2,978
Profit as a percentage of turnover -37.9% Less Arrow -51.0% Less Arrow -223.8%
Return on assets (ROA) -18.4% Less Arrow -19.0% Less Arrow -34.5%
Current ratio 313.2% More Arrow 434.2% More Arrow 747.7%
Return on equity (ROE) -136.5% More Arrow -53.4% More Arrow -50.9%
Change turnover 271,363 More Arrow 383,253 Less Arrow 166,130
Change turnover % 50% More Arrow 250% More Arrow 26141%
Chg. No. of employees 95 Less Arrow 30 More Arrow 33
Chg. No. of employees % 110% Less Arrow 54% More Arrow 143%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.